Kura Oncology officer proposes $71.5K stock sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kura Oncology, Inc. (KURA) officer Brian Powl reported a proposed sale of 9,196 shares of common stock, with an aggregate market value of 71,452.92 and an approximate sale date of November 16, 2026. The shares were acquired from the issuer as restricted stock units on November 13, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The notice also lists four sales in the prior three months.
Key Figures
Key Terms
RSU financial
Restricted Stock Units financial
10b5-1 Sales regulatory
Sell-to cover financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior KURA stock sales are listed for Brian Powl?
AI-generated analysis. How Rhea-AI works. Not financial advice.